肝移植术后肝癌复发

Hepatocellular carcinoma recurrence after liver transplantation

  • 摘要: 肝移植是肝癌根治性治疗的重要手段之一。我国肝移植事业10年来取得了突出的成就,随着外科技术日臻成熟,肝癌肝移植受者术后并发症发生率、院内病死率均显著下降,但是肝移植术后肝癌复发仍然制约着手术的长期疗效。肝移植术后肝癌复发与肝癌患者术前的筛选、列队优先、局部治疗以及术后处理等过程息息相关,如何处理好上述治疗环节是决定肝移植手术最终成败的关键。根据国内现状,结合国内外文献报道及临床实践经验,针对上述环节的关键问题进行思考和探讨,为改善我国肝癌肝移植的疗效做出应有的努力。

     

    Abstract: Liver transplantation (LT) is one of the most important curative treatment for hepatocellular carcinoma (HCC). In the past decade, great achievements have been made in the field of liver transplantation in China. The incidence of postoperative complications and hospital mortality have significantly decreased due to growing experience and maturity of surgical techniques. However, tumor relapse after LT still negatively impact on the long-term outcome of patients with HCC. HCC recurrence and patients′ survival after LT are closely related to preoperative screening of patients, listing priority, local treatment and postoperative management. Successful management of these procedures determines the final therapeutic effect of LT on patients with HCC. In this article, the above issues were explored and discussed according to the current situation of domestic transplant community through revision of the literatures in combination with the clinical experiences.

     

/

返回文章
返回